IDA new report commissioned by Boston Scientific highlights growing physician confidence in pulsed field ablation (PFA) as a promising treatment for atrial fibrillation (AFib) in the Asia-Pacific region. The report reveals that while 92% of surveyed physicians expect PFA to become their preferred ablation modality within two years, many patients are not being referred for timely treatment. Key barriers include weak referral pathways, insufficient patient education, and limited healthcare system preparedness. The report emphasizes the need for improved care coordination, expanded education, and supportive policies to ensure patients benefit from advancements in AFib care. Experts stress the importance of shifting toward proactive management and early intervention to address the rising burden of AFib in the region.
Bias read (Center): The article focuses on a medical and healthcare issue rather than overtly political content, though it touches on healthcare policy and systemic challenges. While the report discusses potential policy changes and industry partnerships, it does not take a clear ideological stance. The framing remains
